{
  "id": 14989369,
  "title": "Iambic CEO on taking an AI drug company public",
  "url": "https://urgent.news/2026/10/16/iambic-ceo-on-taking-an-ai-drug-company-public",
  "topic": "ai",
  "section": "AI",
  "published": "2026-10-16T16:10:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/Iambic-ipo-tom-miller-ai-drug-development-discovery/833238/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Fresh off a $150 million IPO, Tom Miller spoke to BioPharma Dive about the roadshow process and how he sees AI’s role in drug development evolving.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}